UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 367

Sortiert nach

circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity

Nature communications, 2021-01, Vol.12 (1), p.295-295, Article 295

2021

Volltextzugriff (PDF)

Metabolism‐associated molecular classification of hepatocellular carcinoma

Molecular oncology, 2020-04, Vol.14 (4), p.896-913

2020

Volltextzugriff (PDF)

Exploring liver cancer biology through functional genetic screens

Nature reviews. Gastroenterology & hepatology, 2021-10, Vol.18 (10), p.690

2021

Volltextzugriff (PDF)

A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer

eLife, 2022-02, Vol.11

2022

Volltextzugriff (PDF)

circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1

Nature communications, 2019-07, Vol.10 (1), p.3200-13, Article 3200

2019

Volltextzugriff (PDF)

STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4

Molecular cancer, 2017-08, Vol.16 (1), p.136-15, Article 136

2017

Volltextzugriff (PDF)

Inducing and exploiting vulnerabilities for the treatment of liver cancer

Nature (London), 2019-10, Vol.574 (7777), p.268-272

2019

Volltextzugriff (PDF)

Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential

International journal of cancer, 2016-04, Vol.138 (8), p.1824-1834

2016

Volltextzugriff (PDF)

EGFR activation limits the response of liver cancer to lenvatinib

Nature (London), 2021-07, Vol.595 (7869), p.730-734

2021

Volltextzugriff (PDF)

Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study

The lancet oncology, 2012-08, Vol.13 (8), p.817-826

2012

Volltextzugriff (PDF)

A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer

eLife, 2020-10, Vol.9

2020

Volltextzugriff (PDF)

Targeting Vacuolar H+-ATPases as a New Strategy against Cancer

Cancer research (Chicago, Ill.), 2007-11, Vol.67 (22), p.10627-10630

2007

Volltextzugriff (PDF)

Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer

Journal of hepatology, 2018-11, Vol.69 (5), p.1057-1065

2018

Volltextzugriff (PDF)

COL4A1 promotes the growth and metastasis of hepatocellular carcinoma cells by activating FAK-Src signaling

Journal of experimental & clinical cancer research, 2020-08, Vol.39 (1), p.148-148, Article 148

2020

Volltextzugriff (PDF)

Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1

Gastroenterology (New York, N.Y. 1943), 2017-09, Vol.153 (3), p.799-811.e33

2017

Volltextzugriff (PDF)

Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR‐338‐3p‐PKLR axis in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2015-10, Vol.62 (4), p.1145-1159

2015

Volltextzugriff (PDF)

Loss of FBP1 facilitates aggressive features of hepatocellular carcinoma cells through the Warburg effect

Carcinogenesis (New York), 2017-02, Vol.38 (2), p.134

2017

Volltextzugriff (PDF)

The asialoglycoprotein receptor suppresses the metastasis of hepatocellular carcinoma via LASS2-mediated inhibition of V-ATPase activity

Cancer letters, 2016-08, Vol.379 (1), p.107-116

2016

Volltextzugriff (PDF)

Integrative analysis of CRISPR screening data uncovers new opportunities for optimizing cancer immunotherapy

Molecular cancer, 2022-01, Vol.21 (1), p.2-2, Article 2

2022

Volltextzugriff (PDF)

circFOXM1 promotes proliferation of non-small cell lung carcinoma cells by acting as a ceRNA to upregulate FAM83D

Journal of experimental & clinical cancer research, 2020-03, Vol.39 (1), p.55-55, Article 55

2020

Volltextzugriff (PDF)

A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer

Cancer biology & medicine, 2022-02, Vol.19 (2), p.136-139

2022

Volltextzugriff (PDF)

Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin

Cancer letters, 2015-01, Vol.356 (2), p.713-720

2015

Volltextzugriff (PDF)

Downregulation of Splicing Factor PTBP1 Curtails FBXO5 Expression to Promote Cellular Senescence in Lung Adenocarcinoma

Current issues in molecular biology, 2024-07, Vol.46 (7), p.7730-7744

2024

Volltextzugriff (PDF)

Have one's view of the important overshadowed by the trivial: chronic progressive external ophthalmoplegia combined with unilateral facial nerve injury: a case report and literature review

Frontiers in neurology, 2024-01, Vol.14, p.1268053

2024

Volltextzugriff (PDF)

Long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with fused in sarcoma

Cancer science, 2017-04, Vol.108 (4), p.653-662

2017

Volltextzugriff (PDF)

1 – 25 von 367

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(339)
Mit Volltextzugriff
(347)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(290)
Life Sciences & Biomedicine
(182)
Humans
(134)
Technology
(79)
Animals
(65)
Oncology
(59)
Female
(58)
Physical Sciences
(57)
Male
(52)
Mice
(48)
Cell Line, Tumor
(47)
Hepatocellular Carcinoma
(43)
Liver Cancer
(38)
Engineering
(37)
Middle Aged
(36)
Liver Neoplasms - Pathology
(34)
Chemistry
(32)
Materials Science
(32)
Liver Neoplasms - Genetics
(31)
Science & Technology - Other Topics
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity

Metabolism‐associated molecular classification of hepatocellular carcinoma

Exploring liver cancer biology through functional genetic screens

A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer

circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1

STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4

Inducing and exploiting vulnerabilities for the treatment of liver cancer

Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential

EGFR activation limits the response of liver cancer to lenvatinib

Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study

A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer

Targeting Vacuolar H+-ATPases as a New Strategy against Cancer

Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer

COL4A1 promotes the growth and metastasis of hepatocellular carcinoma cells by activating FAK-Src signaling

Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1

Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR‐338‐3p‐PKLR axis in hepatocellular carcinoma

Loss of FBP1 facilitates aggressive features of hepatocellular carcinoma cells through the Warburg effect

The asialoglycoprotein receptor suppresses the metastasis of hepatocellular carcinoma via LASS2-mediated inhibition of V-ATPase activity

Integrative analysis of CRISPR screening data uncovers new opportunities for optimizing cancer immunotherapy

circFOXM1 promotes proliferation of non-small cell lung carcinoma cells by acting as a ceRNA to upregulate FAM83D

A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer

Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin

Downregulation of Splicing Factor PTBP1 Curtails FBXO5 Expression to Promote Cellular Senescence in Lung Adenocarcinoma

Have one's view of the important overshadowed by the trivial: chronic progressive external ophthalmoplegia combined with unilateral facial nerve injury: a case report and literature review

Long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with fused in sarcoma

Suchergebnisse filtern